Integra Lifesciences's market cap is currently $983.00M. The company's EPS TTM is $0.54; its P/E ratio is -1.95; Integra Lifesciences is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.80. See an overview of income statement, balance sheet, and cash flow financials.
